About
Insilico Medicine Cayman Topco (HK:3696) — investor relations, events, news, and company updates on 6ix.
Latest News
Yesterday
Insilico's Rentosertib Inhalation Solution Receives IND Clearance for the World's First AI-Driven Candidate to Enter Direct-to-Lung Clinical Study
Apr 21 2026
Insilico Medicine Announces Industry's First Longevity Board to Accelerate AI-Driven Aging Research for Drug Discovery
Mar 13 2026
Insilico Medicine to Announce 2025 Financial Results on March 30, 2026
Mar 6 2026
Insilico and TaiGen Achieve Milestone in Collaboration: Out-Licensed CKD Anemia Candidate ISM4808 Completes first human enrollment and dosing in Phase I clinical trial
Feb 10 2026
AI-Powered R&D Acceleration: Insilico Medicine and CMS announce multiple collaborations in central nervous system and autoimmune diseases
Recent Videos

Insilico Medicine's LifeStar 2 Automation Lab
Apr 27, 2026

Insilico Medicine AI Longevity Board: Can Generative AI Reverse Human Aging? #ai #ainews
Apr 21, 2026

Medicamentos serão desenvolvidos com IA
Apr 20, 2026

Insilico Medicine vs traditional Pharma: How generative AI accelerates the Drug Discovery process!
Apr 20, 2026
Financials
Revenue
HK$56.24 M
Market Cap
HK$32.73 B
EPS
0.00
Translate